Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chiang

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Molecular Cancer Therapeutics|May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT InhibitorsJulie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Nature Chemical Biology|August 31, 2017
Erratum: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Nature Chemical Biology|January 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Nature|May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Molecular Cancer Therapeutics|May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT InhibitorsJulie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Nature Chemical Biology|August 31, 2017
Erratum: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Nature Chemical Biology|January 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Nature|May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Pageof 11